European Journal of Cancer
Volume 46, Issue 2 , Pages 284-297 , January 2010

Redefining the role of interferon in the treatment of malignant diseases

  • Sergio Bracarda

      Affiliations

    • Department of Oncology and U.O.C. of Medical Oncology, Ospedale San Donato, Azienda USL-8, 52100 Arezzo, Italy
    • Corresponding Author InformationCorresponding author: Address: Department of Oncology and U.O.C. of Medical Oncology, Ospedale San Donato, AUSL-8, Via Pietro Nenni, 20, 52100 Arezzo, Italy. Tel.: +39 0575 25 5439; fax: +39 0575 25 5435.
    • ,
  • Alexander M.M. Eggermont

      Affiliations

    • Erasmus University MC – Daniel den Hoed Cancer Center, 3075 EA Rotterdam, The Netherlands
    • ,
  • Jan Samuelsson

      Affiliations

    • Karolinska Institute, Department of Clinical Science and Education, Department of Internal Medicine, Stockholm South Hospital, 118 83 Stockholm, Sweden

Received 28 July 2009 ,Revised 18 September 2009 ,Accepted 9 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00760-6

doi: 10.1016/j.ejca.2009.10.013

European Journal of Cancer
Volume 46, Issue 2 , Pages 284-297 , January 2010

Article Tools

* Image Usage & Resolution